Ainos Receives Institutional Review Board Approval From Shuang Ho Hospital For Its Trial Of VELDONA In Sjögren's Syndrome

Benzinga11/11 21:06

Ainos Third Quarter 2024 Earnings: US$0.33 Loss per Share (Vs US$0.73 Loss in 3Q 2023)

Yahoo Finance11/09 20:40

Ainos Files Complaints With Nasdaq MarketWatch And The SEC Of Concerns Over Large-Volume Sell Orders, Says It 'Suspects That These Trading Activities May Involve Regulatory Violations'

Benzinga11/08 21:05

Ainos Q3 Net Loss $3,699,317

Benzinga11/07 06:12

10-Q：Q3 2024 四半期報告書

SEC11/07 05:20

12 Health Care Stocks Moving In Thursday's After-Market Session

Benzinga10/04 04:31